Do protein Z levels influence the prothrombotic state in atrial fibrillation? [3]

Thrombosis Research

Volumn 106, Issue 4-5, 2002, Pages 269-270

  Marco, Pascual ^a   Marín, Francisco ^a   García, Amaya ^a   Roldán, Vanessa ^b   Lip, Gregory Y H ^c  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b Hospital de San Vicente   (Spain)

^c UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Atrial fibrillation; Hypercoagulable; Protein Z

Indexed keywords

ACETYLSALICYLIC ACID; FATTY ACID BINDING PROTEIN; FIBRINOGEN; PROTHROMBIN; VON WILLEBRAND FACTOR; BIOLOGICAL MARKER; PLASMA PROTEIN; PLASMA PROTEIN Z;

AGED; CARDIOVASCULAR RISK; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCOAGULABILITY; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SINUS RHYTHM; THROMBOEMBOLISM; BLOOD; CASE CONTROL STUDY; THROMBOPHILIA;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; THROMBOPHILIA;

EID: 0037092630     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00142-1     Document Type: Letter

References (10)

1. Lip G.Y.H. Does atrial fibrillation confer a hypercoagulable state? Lancet. 346:1994;1313-1314.
2. Feinberg W.M., Pearce L.A., Hart R.G., Cushman M., Cornell E.S., Lip G.Y.et al. Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study. Stroke. 30:1999;2547-2553.
3. Heppell R.M., Berkin K.E., McLenachan J.M., Davies J.A. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart. 77:1997;407-411.
4. Broze G.J. Protein Z-dependent regulation of coagulation. Thromb. Haemost. 86:2001;8-13.
5. Han X., Fiehler R., Broze G.J. Jr. Characterization of the protein Z-dependent protease inhibitor. Blood. 96:2000;3049-3055.
6. Yin Z.F., Huang Z.F., Cui J.et al. Prothrombotic phenotype of protein Z deficiency. Proc. Natl. Acad. Sci. U. S. A. 97:2000;6734-6738.
7. Vasse M., Guegan-Massardier E., Borg J.Y., Woimant F., Soria C. Frequency of protein Z deficiency in patients with ischaemic stroke. Lancet. 357:2001;933-934.
8. Kobelt K., Biasiutti F.D., Mattle H.P., Lämmle B., Wuillemin W.A. Protein Z in ischaemic stroke. Br. J. Haematol. 114:2001;169-173.
9. Ravi S., Mauron T., Lammle B., Wuillemin W.A. Protein Z in healthy human individuals and in patients with a bleeding tendency. Br. J. Haematol. 102:1998;1219-1223.
10. Miletich J.P., Broze G.J. Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy. Blood. 69:1987;1580-1586.